Progesterone derivatives increase expression of Krox-20 and Sox-10 in rat Schwann cells

Journal of Molecular Neuroscience

Volumn 31, Issue 2, 2007, Pages 149-157

  Magnaghi, Valerio ^a   Ballabio, Marinella ^a   Roglio, Ilaria ^a   Melcangi, Roberto C ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Dihydroprogesterone; Myelin; Progesterone; Schwann cells; Tetrahydroprogesterone; Transcription factors

Indexed keywords

20ALPHA DIHYDROPROGESTERONE; MESSENGER RNA; NEUROSTEROID; PROGESTERONE DERIVATIVE; TETRAHYDROPROGESTERONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR KROX 20; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL CULTURE; COMPUTER ANALYSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL; WESTERN BLOTTING;

RATTUS;

EID: 34248369244     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Azcoitia I., Leonelli E., Magnaghi V., Veiga S., Garcia-Segura L. M., and Melcangi R. C. (2003) Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats. Neurobiol. Aging 24, 853-860.
2. Beato M. (1989) Gene regulation by steroid hormones. Cell 56, 335-344.
3. Boerkoel C. F., Takashima H., Bacino C. A., Daentl D., and Lupski J. R. (2001) EGR2 mutation R359W causes a spectrum of Dejerine-Sottas neuropathy. Neurogenetics 3, 153-157.
4. Bradford M. M. (1976) Arapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann. Biochem. 72, 248-254.
5. Britsch S., Goerich D. E., Riethmacher D., Peirano R. I., Rossner M., Nave K.A., et al. (2001) The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 15, 66-78.
6. Brockes J. P., Raff M. C., Nishiguchi D. J., and Winter J. (1980) Studies on cultured rat Schwann cells: assay for peripheral myelin proteins. J. Neurocytol. 9, 67-77.
7. Cavarretta I. T., Martini L., Motta M., Smith C. L., and Melcangi R. C. (2004) SRC-1 is involved in the control of the gene expression of myelin protein P0. J. Mol. Neurosci. 24, 217-226.
8. Chan J. R., Phillips L. J. II, and Glaser M. (1998) Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. Proc. Natl. Acad. Sci. U. S. A. 95, 10,459-10,464.
9. Chan J. R., Rodriguez-Waitkus P. M., Ng B. K., Lian P., and Glaser M. (2000) Progesterone synthesized by Schwann cells during myelin formation regulates neuronal gene expression. Mol. Biol. Cell 11, 2283-2295.
10. Chavrier P., Vesque C., Galliot B., Vigneron M., Dollé P., Duboule D., and Charnay P. (1990) The segment-specific gene Krox-20 encodes a transcription factor with binding sites in the promoter region of the Hox-1.4 gene. EMBO J. 9, 1209-1218.
11. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal. Biochem. 162, 156-159.
12. Désarnaud F., Bidichandani S., Patel P. I., Baulieu E. E., and Schumacher M. (2000) Glucocorticosteroids stimulate the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. Brain Res. 865, 12-16.
13. Désarnaud F., Do Thi A. N., Brown A. M., Lemke G., Suter U., Baulieu E. E., and Schumacher M. (1998) Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J. Neurochem. 71, 1765-1768.
14. Guennoun R., Benmessahel Y., Delespierre B., Gouézou M., Rajkowski K. M., Baulieu E. E., and Schumacher M. (2001) Progesterone stimulates Krox-20 gene expression in Schwann cells. Mol. Brain Res. 90, 75-82.
15. Jessen K. R. and Mirsky R. (2002) Signals that determine Schwann cell identity. J. Anat. 200, 367-376.
16. Jung-Testas I., Schumacher M., Bugnard H., and Baulieu E. E. (1993) Stimulation of rat Schwann cell proliferation by estradiol: synergism between the estrogen and cAMP. Dev. Brain Res. 72, 282-290.
17. Kuhlbrodt K., Herbarth B., Sock E., Enderich J., Hermans-Borgmeyer I., and Wegner M. (1998a) Cooperative function of POU proteins and SOX proteins in glial cells. J. Biol. Chem. 273, 16,050-16,057.
18. Kuhlbrodt K., Herbarth B., Sock E., Hermans-Borgmeyer I., and Wegner M. (1998b) Sox10, a novel transcriptional modulator in glial cells. J. Neurosci. 18, 237-250.
19. Kuhlbrodt K., Schmidt C., Sock E., Pingault V., Bondurand N., Goossens M., and Wegner M. (1998c) Functional analysis of Sox10 mutations found in human Waardenburg-Hirschsprung patients. J. Biol. Chem. 273, 23,033-23,038.
20. Lambert J. J., Belelli D., Peden D. R., Vardy A. W., and Peters J. A. (2003) Neurosteroid modulation of GABAA receptors. Prog. Neurobiol. 71, 67-80.
21. Li A. W., Morash B., Hollenberg A. N., Ur E., Wilkinson M., and Murphy P. R. (2001) Transcriptional regulation of the leptin gene promoter in rat GH3 pituitary and C6 glioma cells. Mol. Cell. Endocrinol. 176, 57-65.
22. Magnaghi V., Ballabio M., Cavarretta I. T., Froestl W., Lambert J. J., Zucchi I., and Melcangi R. C. (2004) GABA-B receptors in Schwann cells influence proliferation and myelin protein expression. Eur. J. Neurosci. 19, 2641-2649.
23. Magnaghi V., Cavarretta I., Galbiati M., Martini L., and Melcangi R.C. (2001) Neuroactive steroids and peripheral myelin proteins. Brain Res. Rev. 37, 360-371.
24. Magnaghi V., Cavarretta I., Zucchi I., Susani L., Rupprecht R., Hermann B., et al. (1999) P0 gene expression is modulated by androgens in the sciatic nerve of adult male rats. Mol. Brain Res. 70, 36-44.
25. Melcangi R. C., Cavarretta I. T., Ballabio M., Leonelli E., Schenone A., Azcoitia I., et al. (2005) Peripheral nerves: a target for the action of neuroactive steroids. Brain Res. Rev. 48, 328-338.
26. Melcangi R. C., Leonelli E., Magnaghi V., Gherardi G., Nobbio L., and Schenone A. (2003) Mifepristone (RU38486) influences expression of glycoprotein P0 and morphological parameters at the level of rat sciatic nerve: in vivo observations. Exp. Neurol. 184, 930-938.
27. Melcangi R. C., Magnaghi V., Cavarretta I., Martini L., and Piva F. (1998) Age-induced decrease of glycoprotein P0 and myelin basic protein gene expression in the rat sciatic nerve. Repair by steroid derivatives. Neuroscience 85, 569-578.
28. Melcangi R. C., Magnaghi V., Cavarretta I., Zucchi I., Bovolin P., D'Urso D., and Martini L. (1999) Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action. J. Neurosci. Res. 56, 349-357.
29. Melcangi R. C., Magnaghi V., Galbiati M., and Martini L. (2001) Formation and effects of neuroactive steroids in the central and peripheral nervous system. Int. Rev. Neurobiol. 46, 145-176.
30. Mercier G., Turque N., and Schumacher M. (2001) Early activation of transcription factor expression in Schwann cells by progesterone. Mol. Brain Res. 97, 137-148.
31. Nagarajan R., Svaren J., Le N., Araki T., Watson M., and Milbrandt J. (2001) EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 30, 355-368.
32. Notterpek L., Snipes G. J., and Shooter E. M. (1999) Temporal expression pattern of peripheral myelin protein 22 during in vivo and in vitro myelination. Glia 25, 358-369.
33. Paratore C., Goerich D. E., Suter U., Wegner M., and Sommer L. (2001) Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. Development 128, 3949-3961.
34. Pareyson D., Taroni F., Botti S., Morbin M., Baratta S., Lauria G., et al. (2000) Cranial nerve involvement in CMT disease type 1 due to early growth response 2 gene mutation. Neurology 54, 1696-1698.
35. Peirano R. I., Goerich D. E., Reithmacher D., and Wegner M. (2000) Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol. Cell. Biol. 20, 3198-3209.
36. Robles L. D., Frost A. R., Davila M., Hutson A. D., Grizzle W. E., and Chakrabarti R. (2002) Down-regulation of Cdc6, a cell cycle regulatory gene, in prostate cancer. J. Biol. Chem. 277, 25,431-25,438.
37. Schumacher M., Guennoun R., Mercier G., Désarnaud F., Lacor P., Bénavides J., et al. (2001) Progesterone synthesis and myelin formation in peripheral nerves. Brain Res. Rev. 37, 343-359.
38. Sock E., Renner D., Feist H., Leger H., and Wegner M. (1996) Functional comparison of PML-type and archetype strains of JC virus. J. Virol. 70, 1512-1520.
39. Timmerman V., De Jonghe P., Ceuterick C., De Vriendt E., Lofgren A., Nelis E., et al. (1999) Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype. Neurology 52, 1827-1832.
40. Topilko P., Schneider-Manoury S., Levi G., Baron-Van Evercooren A., Chennoufi A. B. Y., Seitanidou T., et al. (1994) Krox-20 controls myelination in the peripheral nervous system. Nature 371, 796-799.
41. Warner L. E., Mancias P., Butler I. J., McDonald C. M., Keppen L., Koob K.G., and Lupski J. R. (1998) Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat. Genet. 18, 382-384.
42. Wegner M. (2000) Transcriptional control in myelinating glia: the basic recipe. Glia 29, 118-123.
43. Wingender E., Chen X., Fricke E., Geffers R., Hehl R., Liebich I., et al. (2001) The TRANSFAC system on gene expression regulation. Nucleic Acids Res. 29, 281-283.
44. Xu C., Inokuma M. S., Denham J., Golds K., Kundu P., Gold J. D., and Carpenter M. K. (2001) Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 19, 971-974.
45. Yoshihara T., Kanda F., Yamamoto M., Ishihara H., Misu K., Hattori N., et al. (2001) Anovel missense mutation in the early growth response 2 gene associated with late-onset Charcot-Marie-Tooth disease type 1. J. Neurol. Sci. 184, 149-153.